Pharmaceuticals news and pharmaceuticals widget
Friday, November 14, 2008 ( change date )
GSK commences tender offer to acquire Genelabs Technologies, Inc.
GlaxoSmithKline announced that Gemstone Acquisition Corporation, a wholly-owned subsidiary of GSK, is commencing a cash tender offer to purchase all outstanding shares of common stock of Genelabs ...
bionity.com Friday, November 14, 2008Merck Serono Launches Expansion of Flagship Biotech Center to Meet Growing Patient Needs
Merck Serono, the division for innovative pharmaceuticals of Merck KGaA, Darmstadt, Germany, held a cornerstone ceremony at the Merck Serono Biotech Center (MSBC), its production site in ...
bionity.com Friday, November 14, 2008Novexel?s NXL104/ceftazidime Combination Commences Phase II Clinical Trial
Novexe announced that its most advanced injectable antibacterial, which combines Novexel?s broad spectrum beta-lactamase inhibitor, NXL104, with the well established cephalosporin antibiotic, ...
bionity.com Friday, November 14, 2008Research 'A' team to fast track Bionic Eye, Australian consortium announced
Tens of thousands of people with severe vision loss are set to benefit after the announcement of a landmark partnership of world-leading Australian research institutes. Bionic Vision Australia will ...
bionity.com Friday, November 14, 2008Clamelle Chlamydia Test Kits sold in UK pharmacies
Actavis Group is pleased to announce that Clamelle Azithromycin 500mg Tablets and Clamelle Chlamydia Test Kits are now available for pharmacy distribution in the UK. - - Clamelle Chlamydia Service - Th... [WebWire - Friday, november 14, 2008]
Webwire Friday, November 14, 2008FDA Approves Low-dose Regimen of Premarin Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia Painful Sexual Intercourse
Agency Grants New Indication for Bothersome Vaginal Symptom Associated With Menopause - - Collegeville, Pa. - PREMARIN® (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Fo... [WebWire - Friday, november 14, 2008]
Webwire Friday, November 14, 2008Adeona Pharmaceuticals, Inc.: Adeona Pharmaceuticals Announces Clinical Update and Third Quarter 2008 Results
ANN ARBOR, MI (MARKET WIRE) Adeona Pharmaceuticals, Inc. (AMEX: AEN), a pharmaceutical company developing innovative late-stage drug candidates for the treatment of autoimmune and central nervous system (CNS) diseases, today announced its clinical update and results for its third quarter of 2008.
Marketwire.com Friday, November 14, 2008GlaxoSmithKline cut to neutral by UBS
LONDON (MarketWatch) -- GlaxoSmithKline , europe's largest drugmaker, was downgraded to neutral from buy by UBS. The broker cited its 35% rise against the FTSE since Feb. 11. "Although the dividend yield still sits at an attractive 5% and interesting pipeline catalysts remain, valuation no longer offers what to us was a clear growth-value mismatch," the brokerage said.
Market Watch Friday, November 14, 2008Boeing, SPEEA reach tentative agreement
Boeing and the Society of Professional Engineering Employees in Aerospace Local 2001 reached tentative agreement Friday on new four-year contracts covering 21,000 engineers and technical workers.
bizjournals Friday, November 14, 2008Almost Family announces acquisition
Louisville-based Almost Family Inc., a provider of home health nursing services, said Friday that it reached an agreement to acquire the assets of the Medicare-certified home health agency owned by Fairfield Medical Center, located near Columbus, Ohio. (AFAM)
bizjournals Friday, November 14, 20081 2

PREVIEW
OF YOUR NEWS WIDGET
INSTALL YOUR WIDGET